Solution structure of a calmodulin-binding domain in the carboxy-terminal region of HIV type 1 gp160

AIDS Research and Human Retroviruses

Volumn 24, Issue 4, 2008, Pages 607-616

  Sham, S W Simon ^a   McDonald, Jay M ^a,b,c,d   Micoli, Keith J ^b,c   Krishna, N Rama ^a,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALMODULIN; FAS ANTIGEN; GLYCOPROTEIN GP 160; HISTIDINE; ISOLEUCINE; PROLINE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ANALYSIS;

CALMODULIN; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS;

EID: 42649125916     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0202     Document Type: Article

References (22)

1. Micoli KJ, Pan G, Wu Y, Williams JP, Cook WJ, and McDonald JM: Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. J Biol Chem 2000;275:1233-1240.
2. Micoli KJ, Mamaeva O, Piller SC, Barker JL, Pan G, Hunter E, and McDonald JM: Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication. Virology 2006;344:468-479.
3. Pan Z, Radding W, Zhou T, Hunter E, Mountz J, and McDonald JM: Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. Am. J. Pathol. 1996;149:903-910.
4. Radding W, Pan ZQ, Hunter E, Johnston P, Williams JP, and McDonald JM: Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. Biochem Biophys Res Commun 1996;218:192-197.
5. + T-cells from patients with AIDS. Immunopharmacology 1998;40:91-103.
6. Srinivas SK, Srinivas RV, Anantharamaiah GM, Compans RW, and Segrest JP: Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem 1993;268:22895-22899.
7. Tencza SB, Miller MA, Islam K, Mietzner TA, and Montelaro RC: Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein. J Virol 1995;69:5199-5202.
8. Ishikawa H, Sasaki M, Noda S, and Koga Y: Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus Type 1 gp160 to calmodulin. J Virol 1998;72:6574-6580.
9. Tencza SB, Mietzner TA, and Montelaro RC: Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants. AIDS Res Hum Retroviruses 1997;13:263-269.
10. Yap KL, Kim J, Truong K, Sherman M, Yuan T, and Ikura M: Calmodulin target database. J Struct Funct Genomics 2000;1:8-14.
11. Sönnichsen FD, Van Eyk JE, Hodges RS, and Sykes BD: Effect of trifluoroethanol on protein secondary structure: An NMR and CD study using a synthetic actin peptide. Biochemistry 1992;22;31(37):8790-8798.
12. Buck M: Trifluoroethanol and colleagues: Cosolvents come of age. Recent studies with peptides and proteins. Q Rev Biophys 1998;31(3):297-355.
13. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A: NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995;6:277-293.
14. Wuthrich K: NMR of Proteins and Nucleic Acids. New York: John Wiley & Sons, Inc., 1986.
15. Bartels Ch, Xia T-H, Billeter M, Guntert P, and Wuthrich K: The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J Biomol NMR 1995;6:1-10.
16. Guntert P: Automated NMR structure calculation with CYANA. Methods Mol Biol 2004;278:353-78.
17. Wishart DS, Sykes BD, and Richards FM: Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 1991;222:311-333.
18. Yuan T, Mietzner TA, Montelaro RC, and Vogel HJ: Characterization of the calmodulin binding domain of SIV transmembrane glycoprotein by NMR and CD spectroscopy. Biochemistry 1995;34:10690-10696.
19. Venable RM, Pastor RW, Brooks BR, and Carson FW: Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res Hum Retroviruses 1989;5:7-22.
20. Koenig BW, Ferretti JA, and Gawrisch K: Site-specific deuterium order parameters and membrane-bound behavior of a peptide fragment from the intracellular domain of HIV-1 gp41. Biochemistry 1999;38:6327-6334.
21. Ikura M, Clore GM, Gronenborn AM, Zhu G, Klee CB, and Bax A: Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 1992;256:632-638.
22. Yuan T, Tencza S, Mietzner TA, Montelaro RC, and Vogel HJ: Calmodulin binding properties of peptide analogues and fragments of calmodulin-binding domain of simian immunodeficiency virus transmembrane glycoprotein 41. Biopolymers 2001;58:50-62.